BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 19, 2024
Home
»
Newsletters
» BioWorld Asia
BioWorld Asia
Nov. 2, 2005
View Archived Issues
Map Of Changes Promises To Unmask Multitude Of Genes
Read More
NicOx Licenses Respiratory Drug To Topigen For 54.9M
Read More
CAT Paying $14M In Shares For Genencor Cancer Drugs
Read More
Ark's Gene Therapy Product Cerepro Under Review In EU
Read More
AM-Pharma Gets 9M In First Closing Of Series B Round
Read More
Other News To Note
Read More
CAT, Abbott Settle Humira Dispute: Abbott Pays $255M
Ending a 2-year-old dispute, Cambridge Antibody Technology plc and Abbott Laboratories reached an agreement concerning Humira royalties payable to CAT under a 1995 deal. (BioWorld International)
Read More
2005's Second German IPO Prices At Low End Of Range
Read More